ISO3CD,X,Y,GeoArea_Code,GeoArea_Desc,GoalCode,GoalDesc,TargetCode,TargetDesc,IndicatorCode,IndicatorDesc,IndicatorTier,SeriesCode,SeriesDesc,SeriesRelease,ReportingType_Code,ReportingType_Desc,Units_Code,Units_Desc,Footnotes_2000,Footnotes_2001,Footnotes_2002,Footnotes_2003,Footnotes_2004,Footnotes_2005,Footnotes_2006,Footnotes_2007,Footnotes_2008,Footnotes_2009,Footnotes_2010,Footnotes_2011,Footnotes_2012,Footnotes_2013,Footnotes_2014,Footnotes_2015,Footnotes_2016,Nature_Code_2000,Nature_Code_2001,Nature_Code_2002,Nature_Code_2003,Nature_Code_2004,Nature_Code_2005,Nature_Code_2006,Nature_Code_2007,Nature_Code_2008,Nature_Code_2009,Nature_Code_2010,Nature_Code_2011,Nature_Code_2012,Nature_Code_2013,Nature_Code_2014,Nature_Code_2015,Nature_Code_2016,Source_2000,Source_2001,Source_2002,Source_2003,Source_2004,Source_2005,Source_2006,Source_2007,Source_2008,Source_2009,Source_2010,Source_2011,Source_2012,Source_2013,Source_2014,Source_2015,Source_2016,TimeDetail_2000,TimeDetail_2001,TimeDetail_2002,TimeDetail_2003,TimeDetail_2004,TimeDetail_2005,TimeDetail_2006,TimeDetail_2007,TimeDetail_2008,TimeDetail_2009,TimeDetail_2010,TimeDetail_2011,TimeDetail_2012,TimeDetail_2013,TimeDetail_2014,TimeDetail_2015,TimeDetail_2016,Value_2000,Value_2001,Value_2002,Value_2003,Value_2004,Value_2005,Value_2006,Value_2007,Value_2008,Value_2009,Value_2010,Value_2011,Value_2012,Value_2013,Value_2014,Value_2015,Value_2016,Latest_Year,Latest_Value
,,,1,World,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,15,17,17,18,20,30,32,33,35,38,39,46,49,54,56,60,64,2016.0,64
BGR,25.23763153,42.75731323,100,Bulgaria,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,83,85,79,89,91,92,93,94,94,93,96,94,94,94,89,87,88,2016.0,88
MMR,96.51752295,21.19332882,104,Myanmar,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,,E,E,E,E,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,57,65,75,80,,80,82,78,86,2016.0,86
BDI,29.89080992,-3.366387428,108,Burundi,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51,60,65,72,2016.0,72
,,,11,Western Africa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,4,4,7,12,15,2016.0,15
BLR,28.04940161,53.54193075,112,Belarus,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,92,97,98,98,98,98,95,99,99,99,99,99,97,99,98,99,98,2016.0,98
KHM,104.922836,12.71163737,116,Cambodia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41,49,59,58,58,2016.0,58
DZA,2.678164227,28.15940032,12,Algeria,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,78,73,93,96,94,94,98,95,96,98,95,96,95,93,99,99,96,2016.0,96
CAN,-101.6575058,57.72360191,124,Canada,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94,92,90,88,86,2016.0,86
,,,13,Central America,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,70.10713,71,64,72,73,73,69,65,73,71,70,75,72,60,74,75,84,2016.0,84
CPV,-23.63544151,15.07791834,132,Cabo Verde,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,99,94,89,79,95,95,2016.0,95
,,,135,Caucasus and Central Asia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,80,86,90,92,94,86,80,73,66,61,80,97,97,97,98,98,98,2016.0,98
,,,14,Eastern Africa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,2,8,19,31,2016.0,31
,,,142,Asia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,6,10,10,12,12,31,35,37,41,45,48,59,62,71,72,75,80,2016.0,80
,,,143,Central Asia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,91.78499,93.20575,95.80018,96.78936,98.02469,88.49198,81.18998,71.26636,63.09406,56.37397,77.97569,98.46241,98.15005,97.77869,98.67245,97.7399,98.61274,2016.0,98.61274
LKA,80.70489654,7.614693343,144,Sri Lanka,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,52,92,90,95,99,98,97,97,97,99,99,99,99,99,99,99,2016.0,99
,,,145,Western Asia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,18,68,66,69,69,75.39853,71,77,80,81,81,79,75,77,75,74,76,2016.0,76
,,,15,Northern Africa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,52.45078,54.41089,56.34756,56.59766,68.02373,68.17647,68.47933,68.06207,55.38707,55.64696,56.00045,60.35722,64.18877,74.25883,81.86496,88.77256,90.7316,2016.0,90.7316
,,,150,Europe,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,51,52,64,65,70,71,72.11386,73.2733,73.2733,71.94241,78.51691,79.26246,80.05062,85.57322,87,87,86,2016.0,86
,,,151,Eastern Europe,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,90,91,95,97,97,96,97,97,97,93,89,91,90,90,90,89,85,2016.0,85
CHL,-71.23029019,-35.2652885,152,Chile,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,96,96,95,95,89,89,84,77,74,78,88,89,87,2016.0,87
,,,154,Northern Europe,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,67,72,72,74,73,73,72,71,71,74,77,77,79,80,80,81,84,2016.0,84
,,,155,Western Europe,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,2,2,41,43,45,48,52,52,53,53,80,80,83,81,86,86,86,2016.0,86
CHN,104.1403375,32.30955217,156,China,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,84,94,92,95,98,99,99,99,99,99,99,99,2016.0,99
,,,17,Middle Africa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,5,2016.0,5
COL,-73.07446751,3.888209046,170,Colombia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,84,83,93,70,70,73,85,93,70,71,74,76,80,72,88,86,87,2016.0,87
,,,18,Southern Africa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,53,48,44,49,48,47,53,50,54,62,56,55,55,56,61,65,68,2016.0,68
COK,-159.7711391,-21.22696458,184,Cook Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,70,50,61,88,86,97,99,98,95,61,98,96,98,95,98,95,90,2016.0,90
CRI,-84.19712782,9.970998683,188,Costa Rica,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,89,84,79,80,95,92,90,90,87,2016.0,87
,,,19,Americas,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,43,45,42,40,41,40,39,37,39,42,43,47,49,45,54,53,54,2016.0,54
HRV,17.95874553,45.45172212,191,Croatia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,98,98,98,98,98,98,98,98,98,98,98,97,97,97,96,96,2016.0,96
CUB,-79.54460144,22.10030366,192,Cuba,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,53,97,99,98,95,98,95,96,97,98,99,99,2016.0,99
CYP,33.22285964,35.05659437,196,Cyprus,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,93,89,88,88,88,88,88,88,88,88,2016.0,88
,,,199,Least Developed Countries (LDCs),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,0,0,0,0,0,1,2,1,4,5,5,6,8,17,22,29,37,2016.0,37
,,,2,Africa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,11,11,11,11,13,13,13,12,10,11,11,10,12,15,19,26,32,2016.0,32
AND,1.576257417,42.54548611,20,Andorra,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,80,86,82,86,82,89,91,90,88,90,2016.0,90
,,,202,Sub-Saharan Africa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,3,3,2,3,3,2,3,2,3,3,3,3,4,5,8,16,22,2016.0,22
CZE,15.33151382,49.73913871,203,Czechia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,98,98,98,98,98,98,98,98,98,98,98,98,99,99,96,99,93,2016.0,93
DNK,9.326571283,56.03829721,208,Denmark,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,87,92,88,88,91,91,88,87,85,85,86,87,86,84,80,85,2016.0,85
,,,21,Northern America,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,0,0,0,0,0,0,0,0,8,8,8,8,8,8,8,8,8,2016.0,8
DMA,-61.3493756,15.43391378,212,Dominica,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,62,99,99,99,99,99,95,95,95,95,94,94,91,89,94,92,2016.0,92
ECU,-78.37005241,-1.447785891,218,Ecuador,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,99,91,92,81,70,59,76,76,2016.0,76
SLV,-88.86862995,13.73603564,222,El Salvador,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,77,80,85,89,86,79,82,78,81,95,85,85,88,87,2016.0,87
ERI,38.11074289,16.12894644,232,Eritrea,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75,85,2016.0,85
EST,25.84093481,58.68487172,233,Estonia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,89,84,94,96,97,98,98,96,97,96,95,95,94,92,93,92,92,2016.0,92
AGO,17.57817062,-12.33724746,24,Angola,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26,26,2016.0,26
FJI,177.9660884,-17.83301566,242,Fiji,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,74,94,94,94,94,94,94,94,94,94,94,94,2016.0,94
FIN,23.308447,61.91586738,246,Finland,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85,2016.0,85
FRA,2.457288129,46.62660861,250,France,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,67,67,72,67,77,78,79,2016.0,79
DJI,42.18274707,11.56004161,262,Djibouti,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,82,82,82,82,82,2016.0,82
GEO,43.3713615,42.04813028,268,Georgia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,8,40,57,75,87,88,92,87,71,84,77,79,89,87,91,85,2016.0,85
GMB,-15.39944785,13.45295927,270,Gambia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,56,53,73,81,79,2016.0,79
PSE,35.25694122,31.94347933,275,State of Palestine,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,95,94,93,94,94,97,92,87,99,97,94,95,97,98,99,99,99,2016.0,99
DEU,10.3806066,51.08862743,276,Germany,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,77,83,89,91,90,92,92,93,93,93,93,93,93,93,93,2016.0,93
ATG,-61.7999755,17.07761471,28,Antigua and Barbuda,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,46,68,78,83,94,92,89,90,87,87,87,87,2016.0,87
GHA,-1.205623522,7.964825185,288,Ghana,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,52,54,67,63,75,2016.0,75
,,,29,Caribbean,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,1,11,11,11,12,23,31,31,30,28,27,26,27,27,28,28,37,2016.0,37
KIR,-157.5643005,1.768837732,296,Kiribati,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,35,21,61,9,84,80,76,79,2016.0,79
,,,30,Eastern Asia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,1.72766,2.74229,3.52099,3.5589,3.47581,77.31445,86.40845,84.9124,94.10626,97.65551,98.84364,98.55484,98.53231,98.5482,98.63542,98.56869,98.55772,2016.0,98.55772
GRC,22.58307827,39.47301873,300,Greece,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,77,77,77,77,77,83,83,83,83,83,2016.0,83
GRD,-61.68248568,12.11238395,308,Grenada,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,74,68,61,81,87,86,86,78,86,85,75,85,92,89,85,2016.0,85
AZE,50.01064725,40.39229544,31,Azerbaijan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,65,67,66,67,67,68,75,79,83,89,92,95,98,98,98,98,2016.0,98
ARG,-65.14563274,-35.19446255,32,Argentina,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,56,56,83,80,93,88,91,84,88,96,94,91,89,83,96,87,88,2016.0,88
GTM,-91.2312746,15.00273719,320,Guatemala,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65,2016.0,65
GUY,-58.97322037,4.788012784,328,Guyana,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,88,80,71,63,72,74,90,84,84,82,84,90,95,91,95,94,2016.0,94
HTI,-72.33640958,18.40426539,332,Haiti,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26,2016.0,26
,,,34,Southern Asia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,3,4,4,4,4,4,4,4,5,9,11,31,40,54,61,67,73,2016.0,73
HUN,19.41221519,47.1651448,348,Hungary,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,99,99,99,99,99,99,99,99,99,99,96,99,99,99,99,99,99,2016.0,99
,,,35,South-Eastern Asia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,9.68686,8.42011,8.55614,16.87892,20.21892,22.02036,32.61537,44.44848,56.29388,61.07212,63.40099,69.2225,64.7325,73.62507,56.15277,58.45271,69.68646,2016.0,69.68646
ISL,-19.02116966,64.79134763,352,Iceland,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,92,89,90,93,95,94,93,92,90,97,94,93,94,95,2016.0,95
IND,79.3608464,22.34642074,356,India,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,27,36,51,60,69,76,2016.0,76
AUS,134.3499412,-25.57717202,36,Australia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,85,85,87,89,80,82,88,90,91,92,93,93,94,2016.0,94
IDN,113.9174,-0.994582204,360,Indonesia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,21,29,23,50,73,66,67,74,76,78,76,28,31,56,2016.0,56
IRN,54.19766348,32.74370885,364,Iran (Islamic Republic of),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,99,94,96,96,99,92,98,97,96,99,99,99,97,97,98,98,98,2016.0,98
IRQ,43.76606267,33.05013795,368,Iraq,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,52,48,45,41,58,52,64,76,87,77,77,68,57,60,62,64,2016.0,64
ISR,34.62277992,31.06164552,376,Israel,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,97,97,97,97,96,96,90,91,92,93,87,89,95,96,97,97,2016.0,97
ITA,12.57022427,42.79917282,380,Italy,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,84,83,83,83,2016.0,83
JAM,-77.31068409,18.15616857,388,Jamaica,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,96,96,95,95,91,88,84,80,78,56,60,76,71,72,83,85,2016.0,85
,,,39,Southern Europe,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,17,24,25,26,51,52,52,59,59,57,58,58,58,88,89,89,89,2016.0,89
JPN,139.2716103,36.6554539,392,Japan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,78,92,97,92,92,93,94,93,93,2016.0,93
KAZ,66.65359159,48.01963494,398,Kazakhstan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,98,95,98,99,99,96,99,99,99,99,99,99,97,99,99,98,99,2016.0,99
AFG,66.02688198,33.83160199,4,Afghanistan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,2,9,18,4,23,24,29,31,33,35,39,39,39,2016.0,39
AUT,14.14172472,47.58704857,40,Austria,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,35,34,39,46,47,54,61,56,62,64,69,73,78,82,87,88,89,2016.0,89
JOR,37.13024774,30.65365973,400,Jordan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,83,87,90,91,98,92,88,97,90,90,95,95,96,98,98,96,99,2016.0,99
KEN,37.86096816,0.534797278,404,Kenya,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28,32,2016.0,32
PRK,127.1803633,40.1462645,408,Democratic People's Republic of Korea,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,98,98,99,99,99,99,99,97,98,2016.0,98
KOR,127.8610254,36.45201023,410,Republic of Korea,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,39,67,95,95,99,99,99,99,99,99,98,98,97,95,96,97,97,2016.0,97
KWT,47.49305029,29.53949468,414,Kuwait,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,77,96,90,86,94,99,99,99,99,86,96,96,2016.0,96
KGZ,74.52324839,41.46204516,417,Kyrgyzstan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,96,98,98,98,98,98,97,95,97,98,98,98,98,97,97,96,98,2016.0,98
,,,419,Latin America and the Caribbean,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,60.06961,61.06421,56.81798,55.55228,56.96647,55.79256,54.55838,52.20517,55.5606,59.75887,60.65385,67.52138,66.1557,61.19683,73.11566,71.75119,73.47605,2016.0,73.47605
LBN,35.89391711,33.92152458,422,Lebanon,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,56,42,28,14,24,34,45,55,65,75,75,75,75,75,75,75,75,2016.0,75
LSO,28.25362195,-29.58041814,426,Lesotho,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,46,50,47,56,68,80,80,80,81,81,82,82,82,82,82,82,2016.0,82
LVA,26.42461876,56.64196636,428,Latvia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,90,95,96,97,98,99,99,98,94,92,93,92,92,92,89,92,89,2016.0,89
,,,432,Landlocked developing countries (LLDCs),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,12,13,13,13,13,12,13,10,11,11,13,15,15,17,20,26,34,2016.0,34
LBY,18.0295985,27.04042819,434,Libya,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,81,86,90,95,95,96,97,97,97,97,97,97,95,92,97,96,2016.0,96
BHS,-78.05111663,24.69546597,44,Bahamas,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,95,88,88,84,80,76,78,79,73,69,72,76,74,2016.0,74
LTU,23.90517807,55.33680309,440,Lithuania,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,97,96,95,93,93,95,94,96,96,94,95,94,93,92,92,92,92,2016.0,92
LUX,6.092656563,49.77679538,442,Luxembourg,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86,86,86,86,2016.0,86
MWI,33.4884625,-13.40819859,454,Malawi,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8,61,2016.0,61
MYS,116.8346314,5.452415309,458,Malaysia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,91,90,92,97,95,95,95,99,99,99,99,99,2016.0,99
MDV,73.09672546,-0.614385021,462,Maldives,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,56,76,96,96,96,99,99,97,99,99,2016.0,99
MLT,14.44617519,35.89194275,470,Malta,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,2,31,60,86,77,83,85,85,85,91,88,94,91,86,2016.0,86
BHR,50.5490754,26.04407747,48,Bahrain,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,92,99,97,99,99,99,99,99,97,99,98,98,99,99,99,99,99,2016.0,99
MUS,57.568022,-20.28581998,480,Mauritius,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,80,78,85,80,83,85,90,89,90,85,85,96,92,2016.0,92
MEX,-102.5148166,23.93378032,484,Mexico,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,98,99,89,96,97,97,91,85,94,92,91,97,92,76,95,96,98,2016.0,98
,,,485,"Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)",3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,84,85,81,77,83,83,82,84,86,87,87,86,81,82,81,79,81,2016.0,81
MNG,103.0728057,46.83892054,496,Mongolia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,75,95,96,98,98,98,96,97,96,97,95,98,98,97,98,98,90,2016.0,90
MDA,28.4650624,47.20236795,498,Republic of Moldova,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,69,96,98,98,99,95,97,98,98,96,95,94,93,90,95,2016.0,95
MNE,19.25214024,42.78717043,499,Montenegro,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,95,96,96,97,97,97,94,95,94,86,2016.0,86
,,,5,South America,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,61.1002,61,58,52,54,51,50,48,50,57,59,68,67,65,77,75,72,2016.0,72
BGD,89.17660788,22.86961622,50,Bangladesh,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35,70,83,83,93,2016.0,93
MAR,-6.281942841,31.8440131,504,Morocco,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,,,,,,,E,E,E,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,91,92,92,92,,,,,,,54,95,99,2016.0,99
MOZ,38.18479941,-14.27963886,508,Mozambique,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51,2016.0,51
ARM,44.93839317,40.29499741,51,Armenia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,94,96,95,93,94,92,85,93,94,96,97,98,97,97,97,97,97,2016.0,97
OMN,57.87743482,21.98805614,512,Oman,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,99,99,98,98,98,97,97,95,98,99,99,99,99,99,99,98,99,2016.0,99
,,,514,"Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)",3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,29,31,37,37,42,42,42,43,49,50,54,54,58,62,63,63,63,2016.0,63
,,,515,Developing regions,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,70,71,70,72,74,76,77,78,80,83,84,84,84,84,84,84,85,2016.0,85
,,,518,Eastern Asia (excluding Japan),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,85,86,86,86,87,87,93,93,97,99,99,99,99,99,99,99,99,2016.0,99
BRB,-59.5346489,13.13648273,52,Barbados,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,12,41,71,99,98,94,96,97,97,96,94,90,89,91,89,87,2016.0,87
NRU,166.92313,-0.528742623,520,Nauru,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,95,83,72,60,50,97,99,99,92,99,99,81,88,94,96,96,2016.0,96
NPL,83.94678863,28.25866332,524,Nepal,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25,2016.0,25
NLD,5.331480568,51.86728884,528,Netherlands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,96,98,98,93,92,92,93,93,92,93,93,92,93,92,91,2016.0,91
,,,53,Australia and New Zealand,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,0,0,0,0,69.69354,69.66722,71.15714,72.67618,65.20184,66.85303,71.91167,89.3009,89.95501,90.95966,91.79603,91.98088,93.16295,2016.0,93.16295
,,,54,Melanesia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,0,0,0,0,0,5,7,7,7,7,7,7,7,7,7,7,7,2016.0,7
NZL,170.4755673,-43.98721568,554,New Zealand,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,86,85,86,86,87,89,2016.0,89
BEL,4.660976456,50.64104975,56,Belgium,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,78,78,81,83,83,83,85,85,85,85,85,2016.0,85
NER,9.400167877,17.42143036,562,Niger,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,16,37,2016.0,37
,,,57,Micronesia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,26,35,47,52,55,54,55,61,52,63,58,71,47,77,75,75,77,2016.0,77
NIU,-169.8601693,-19.05000475,570,Niue,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,99,99,90,86,99,70,99,99,99,99,99,98,98,99,99,99,99,2016.0,99
NOR,11.47846389,61.34311134,578,Norway,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,90,90,90,89,90,91,91,93,95,96,97,94,91,91,92,91,91,2016.0,91
FSM,158.225216,6.880670092,583,Micronesia (Federated States of),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,50,64,65,66,74,84,85,86,84,82,75,75,70,75,75,74,74,2016.0,74
MHL,171.0839119,7.110213497,584,Marshall Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,6,6,70,90,92,71,60,91,79,66,90,74,58,56,53,70,49,2016.0,49
PLW,134.5733878,7.502307591,585,Palau,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,75,83,90,94,98,95,98,83,77,79,39,83,86,98,81,82,95,2016.0,95
PAK,68.80479684,29.36491634,586,Pakistan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,30,51,53,53,53,53,53,53,2016.0,53
PAN,-81.26616623,8.450965746,591,Panama,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,88,88,88,89,89,89,86,83,79,76,73,81,72,68,90,92,92,2016.0,92
PRY,-60.54854225,-21.70216237,600,Paraguay,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,31,61,74,84,80,81,82,79,81,81,77,92,2016.0,92
PER,-71.82093277,-13.58939705,604,Peru,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,9,17,42,56,70,63,54,44,63,66,2016.0,66
PHL,120.8601418,14.16591706,608,Philippines,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,19,10,36,42,54,59,67,66,2016.0,66
,,,61,Polynesia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,4,6,57,73,62,51,39,57,62,41,52,64,64,78,70,63,58,2016.0,58
POL,19.40660158,52.1226733,616,Poland,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,96,96,97,97,96,90,99,98,97,95,94,95,95,93,95,94,94,2016.0,94
PRT,-7.961599811,39.68509315,620,Portugal,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,48,56,64,72,79,87,95,95,95,95,95,96,96,96,96,95,95,2016.0,95
TLS,125.9451052,-8.797497247,626,Timor-Leste,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22,2016.0,22
QAT,51.19152467,25.28355379,634,Qatar,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,91,91,95,98,87,91,95,99,98,99,99,99,95,91,92,2016.0,92
BTN,90.45098484,27.39598568,64,Bhutan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,72,79,85,95,90,89,92,94,90,2016.0,90
ROU,24.98481009,45.83893563,642,Romania,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,96,97,97,97,96,96,96,96,95,94,93,91,90,88,84,80,76,2016.0,76
RUS,99.01404926,61.61899849,643,Russian Federation,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,86,88,93,96,97,97,97,97,97,97,98,97,97,97,97,97,97,2016.0,97
RWA,29.92310194,-1.999842114,646,Rwanda,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87,90,2016.0,90
KNA,-62.76628613,17.33994219,659,Saint Kitts and Nevis,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,99,99,99,98,98,97,96,95,94,99,99,99,90,94,90,90,97,2016.0,97
LCA,-60.96529553,13.89405601,662,Saint Lucia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,89,73,71,69,67,56,45,33,22,63,74,72,80,62,79,95,88,2016.0,88
VCT,-61.19024321,13.24627968,670,Saint Vincent and the Grenadines,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,99,99,86,73,93,88,83,94,94,89,91,92,96,98,99,99,2016.0,99
SMR,12.46329038,43.93841766,674,San Marino,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,96,96,94,93,91,89,88,86,84,88,77,76,82,36,2016.0,36
STP,6.609772265,0.241554875,678,Sao Tome and Principe,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,71,76,76,2016.0,76
SAU,44.54763347,24.12594211,682,Saudi Arabia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,96,96,97,97,97,97,98,98,98,98,97,98,99,98,96,96,2016.0,96
SEN,-14.46636926,14.35920905,686,Senegal,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13,54,75,2016.0,75
SRB,20.805876,44.03145697,688,Serbia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,78,74,75,96,96,98,90,96,97,87,91,90,90,82,91,86,90,2016.0,90
SYC,55.46561591,-4.678053059,690,Seychelles,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,98,99,99,99,99,99,99,98,99,98,99,99,97,98,98,99,2016.0,99
SLE,-11.78306584,8.568604164,694,Sierra Leone,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60,50,2016.0,50
BIH,17.78584332,44.16845548,70,Bosnia and Herzegovina,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,74,86,90,85,88,90,93,95,92,88,91,88,94,93,92,88,78,2016.0,78
SGP,103.8107883,1.361009155,702,Singapore,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,98,96,96,96,96,95,96,96,96,95,95,96,90,90,90,90,88,2016.0,88
SVK,19.48495604,48.70741446,703,Slovakia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,99,99,99,99,98,98,99,98,99,99,99,99,99,99,98,98,97,2016.0,97
VNM,105.802499,10.09643079,704,Viet Nam,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,18,97,96,98,93,83,86,94,92,95,2016.0,95
SVN,14.82209486,46.11958061,705,Slovenia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,98,98,98,98,99,99,99,98,98,98,96,96,96,95,94,96,93,2016.0,93
ZAF,24.67184355,-29.99957544,710,South Africa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,62,54,46,52,51,49,55,52,57,66,59,58,59,56,62,66,70,2016.0,70
ZWE,29.86909584,-19.00075492,716,Zimbabwe,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,,,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63,2016.0,63
BWA,23.81380223,-22.18810073,72,Botswana,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83,85,80,74,2016.0,74
,,,722,Small island developing States (SIDS),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,6,14,14,14,15,23,29,29,28,27,26,27,27,27,27,28,33,2016.0,33
ESP,-3.554078296,40.39211472,724,Spain,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,91,92,94,95,94,90,92,91,90,91,93,94,95,2016.0,95
,,,729,Sudan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24,57,61,69,69,2016.0,69
,,,738,Sub-Saharan Africa (inc. Sudan),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,51,52,53,56,59,62,64,68,70,73,72,72,72,72,74,73,74,2016.0,74
SUR,-55.90626394,4.132603197,740,Suriname,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,18,18,28,44,2016.0,44
,,,746,Northern Africa (exc. Sudan),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,95,96,94,94,95,96,97,97,97,97,97,96,95,97,95,95,95,2016.0,95
SWZ,31.50149288,-26.56471011,748,Eswatini,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,99,99,99,99,99,99,99,99,99,92,52,89,89,89,89,2016.0,89
SWE,14.3775338,60.60103109,752,Sweden,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,94,94,94,95,95,95,95,95,94,95,94,95,95,95,95,95,95,2016.0,95
CHE,8.223158,46.96617097,756,Switzerland,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,71,71,71,83,83,83,86,86,86,87,89,89,2016.0,89
BRA,-53.08432878,-10.77668561,76,Brazil,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,95,95,80,74,68,61,55,49,56,55,53,71,70,69,89,80,72,2016.0,72
SYR,38.50466565,35.01676176,760,Syrian Arab Republic,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,80,83,84,83,82,81,81,81,81,82,82,71,53,51,49,47,52,2016.0,52
TJK,69.294998,38.43069666,762,Tajikistan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,59,72,93,94,98,92,96,90,87,93,95,96,97,92,98,94,97,2016.0,97
THA,101.0202951,15.13089239,764,Thailand,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,99,86,89,92,95,95,94,94,91,91,91,91,91,94,94,95,95,2016.0,95
TON,-175.1959991,-21.19511329,776,Tonga,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,82,85,84,85,85,84,84,84,85,81,86,78,85,85,2016.0,85
TTO,-61.29389504,10.41877263,780,Trinidad and Tobago,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,80,77,73,78,84,78,87,81,80,82,83,85,86,93,79,65,2016.0,65
ARE,53.98279159,23.43322219,784,United Arab Emirates,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,92,92,92,92,92,94,93,93,92,93,94,95,96,98,99,99,99,2016.0,99
TUN,9.572737411,34.11439971,788,Tunisia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,98,99,98,99,99,99,98,98,99,97,98,96,96,98,95,98,97,2016.0,97
TUR,35.42890329,38.9899684,792,Turkey,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,91,83,97,97,98,84,94,92,88,91,86,85,98,88,86,85,2016.0,85
TKM,58.9787665,40.0912346,795,Turkmenistan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,92,94,87,89,90,98,99,98,99,99,99,99,99,99,99,99,99,2016.0,99
TUV,178.6679611,-7.460048071,798,Tuvalu,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,99,97,93,90,86,83,74,82,84,87,90,93,84,91,86,92,2016.0,92
ALB,20.06660928,41.13897007,8,Albania,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,90,93,93,96,97,94,95,98,98,98,99,99,99,98,98,98,2016.0,98
UKR,31.40270802,49.00735945,804,Ukraine,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,99,98,98,99,97,96,98,96,95,68,41,56,54,54,57,57,31,2016.0,31
MKD,21.7007909,41.60048068,807,The former Yugoslav Republic of Macedonia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,95,94,95,97,95,95,96,95,95,97,99,98,96,96,96,93,93,2016.0,93
EGY,29.77468534,26.57438204,818,Egypt,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,97,99,96,97,96,97,97,97,96,96,97,97,92,96,93,92,96,2016.0,96
GBR,-2.23830539,53.27691757,826,United Kingdom of Great Britain and Northern Ireland,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,76,74,74,77,76,75,75,74,75,79,84,85,87,88,89,91,89,2016.0,89
TZA,34.80521182,-6.265332606,834,United Republic of Tanzania,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,29,57,71,2016.0,71
BLZ,-88.70199554,17.19965901,84,Belize,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,87,92,89,90,92,91,98,93,92,92,95,96,2016.0,96
BFA,-1.742843829,12.27491081,854,Burkina Faso,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,50,50,2016.0,50
URY,-56.01387025,-32.8002838,858,Uruguay,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92,93,93,92,2016.0,92
UZB,63.11944558,41.77560518,860,Uzbekistan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,98,98,97,98,99,81,63,44,26,8,54,99,99,99,99,99,99,2016.0,99
VEN,-66.15642084,7.121324748,862,Venezuela (Bolivarian Republic of),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,6,31,26,33,38,50,52,53,2016.0,53
WSM,-172.4430749,-13.61541469,882,Samoa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,84,65,45,26,6,36,46,14,30,50,52,72,63,48,44,2016.0,44
YEM,45.22389143,15.22242099,887,Yemen,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,21,26,32,35,38,43,46,40,47,45,41,49,2016.0,49
ZMB,27.850329,-14.59701056,894,Zambia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E,E,E,,,,,,,,,,,,,,,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33,47,58,2016.0,58
,,,9,Oceania,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,0,1,2,2,41,43,45,46,41,42,45,56,56,58,59,59,59,2016.0,59
BRN,114.6288563,4.49736984,96,Brunei Darussalam,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,E,"WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017","WHO/UNICEF coverage estimates 2016 revision, July 2017",,,,,,,,,,,,,,,,,,95,95,96,96,97,95,94,92,90,99,93,93,92,92,96,97,97,2016.0,97
ATA,21.47585697,-80.40897662,10,Antarctica,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASM,-170.7187269,-14.30587306,16,American Samoa,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BMU,-64.78155012,32.27881922,60,Bermuda,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BOL,-64.66224284,-16.71273412,68,Bolivia (Plurinational State of),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BVT,3.410732868,-54.43295905,74,Bouvet Island,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
IOT,72.38715553,-7.299281071,86,British Indian Ocean Territory,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLB,160.1584117,-9.622391719,90,Solomon Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGB,-64.63294223,18.42256578,92,British Virgin Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMR,12.7419827,5.692387031,120,Cameroon,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CYM,-81.16740559,19.32266656,136,Cayman Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CAF,20.93559492,7.003720791,140,Central African Republic,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCD,18.66618401,15.36279341,148,Chad,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CXR,105.6426067,-10.4882473,162,Christmas Island,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CCK,96.82633757,-12.18600682,166,Cocos (Keeling) Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
COM,43.34234565,-11.66121732,174,Comoros,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MYT,45.14015057,-12.82217691,175,Mayotte,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
COG,15.22052612,-0.840544119,178,Congo,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
COD,23.65496507,-2.877154732,180,Democratic Republic of the Congo,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BEN,2.339933594,9.65401646,204,Benin,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DOM,-70.49847576,18.89832088,214,Dominican Republic,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNQ,10.46535826,1.565792376,226,Equatorial Guinea,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETH,39.63505296,8.631223181,231,Ethiopia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRO,-7.122044325,62.21228119,234,Faroe Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLK,-58.75246778,-51.74562601,238,Falkland Islands (Malvinas),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGS,-36.90662765,-54.20736749,239,South Georgia and the South Sandwich Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALA,19.80945969,60.1544901,248,land Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GUF,-53.23619089,3.922673437,254,French Guiana,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PYF,-149.4052367,-17.67709294,258,French Polynesia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ATF,69.64849091,-49.6068576,260,French Southern Territories,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GAB,11.78727747,-0.60687619,266,Gabon,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GIB,-5.347561686,36.13895036,292,Gibraltar,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GRL,-41.39371316,74.75625681,304,Greenland,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLP,-61.64762115,16.14416917,312,Guadeloupe,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GUM,144.7029305,13.35485404,316,Guam,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GIN,-11.28173419,11.00210343,324,Guinea,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMD,73.52633626,-53.09106147,334,Heard Island and McDonald Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAT,12.45315803,41.90343751,336,Holy See,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HND,-86.59974381,14.82243161,340,Honduras,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HKG,114.0266445,22.41749934,344,"China, Hong Kong Special Administrative Region",3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
IRL,-7.121425272,53.25274054,372,Ireland,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CIV,-5.552690016,7.62211586,384,Cte d'Ivoire,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAO,101.9901968,20.27482773,418,Lao People's Democratic Republic,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LBR,-9.311879038,6.448381009,430,Liberia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LIE,9.552985019,47.14167005,438,Liechtenstein,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAC,113.5665388,22.1237259,446,"China, Macao Special Administrative Region",3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDG,46.6982339,-19.38514785,450,Madagascar,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLI,-3.522016039,17.35311254,466,Mali,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTQ,-60.91544135,14.56086108,474,Martinique,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MRT,-10.33187259,20.26089546,478,Mauritania,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MCO,7.424214814,43.73532918,492,Monaco,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSR,-62.19261223,16.73558313,500,Montserrat,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAM,17.21907885,-22.13817068,516,Namibia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANT,-68.30676179,12.22720635,530,Netherlands Antilles,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CUW,-68.95033464,12.15058042,531,Curaao,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ABW,-69.97050586,12.50878756,533,Aruba,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SXM,-63.06198692,18.03926508,534,Sint Maarten (Dutch part),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NCL,165.5067368,-21.41742531,540,New Caledonia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VUT,167.0679779,-15.34445547,548,Vanuatu,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NIC,-85.03060315,12.84210839,558,Nicaragua,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGA,8.097363256,9.585789025,566,Nigeria,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFK,167.9515548,-29.03230018,574,Norfolk Island,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNP,145.7582114,15.19099517,580,Northern Mariana Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
UMI,-162.4343752,5.874443968,581,US Minor Outlying Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSM,158.225216,6.880670092,583,"Micronesia, Federated States of",3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PNG,145.8587761,-6.756057077,598,Papua New Guinea,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PCN,-128.3225873,-24.37538456,612,Pitcairn,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNB,-14.40182514,12.11760394,624,Guinea-Bissau,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PRI,-66.47591017,18.22753799,630,Puerto Rico,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
REU,55.53171398,-21.13183266,638,Runion,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BLM,-62.83173536,17.89513362,652,Saint Barthlemy,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SHN,-5.705752501,-15.96503946,654,Saint Helena,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AIA,-63.05651612,18.21525315,660,Anguilla,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAF,-63.04505461,18.0882685,663,Saint Martin (French Part),3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPM,-56.33682442,46.85812735,666,Saint Pierre and Miquelon,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SOM,46.20367477,4.406485729,706,Somalia,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSD,30.32618773,7.290839152,728,South Sudan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ESH,-13.13515523,24.66265342,732,Western Sahara,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDN,29.95650159,16.02643066,736,Sudan,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SJM,13.38071013,78.82894131,744,Svalbard and Jan Mayen Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGO,0.97835765,8.532096072,768,Togo,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TKL,-171.8154473,-9.214545558,772,Tokelau,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TCA,-71.745121,21.80780585,796,Turks and Caicos Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
UGA,32.39100438,1.279557331,800,Uganda,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MKD,21.7007909,41.60048068,807,"Macedonia, Republic of",3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GBR,-2.23830539,53.27691757,826,United Kingdom,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGY,-2.200712402,49.71561166,831,Guernsey,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
JEY,-2.136773508,49.22353354,832,Jersey,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
IMN,-4.538190305,54.22880901,833,Isle of Man,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TZA,34.80521182,-6.265332606,834,"Tanzania, United Republic of",3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
USA,-99.13830311,39.5277871,840,United States of America,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VIR,-64.76960113,17.73297693,850,United States Virgin Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLF,-176.2034788,-13.28471201,876,Wallis and Futuna Islands,3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",3.b.1,Proportion of the target population covered by all vaccines included in their national programme,2,SH_ACS_MCV2,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),2019.Q1.G.01,G,Global,PERCENT,Percentage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
